Celik Serdar, Eker Anıl, Bozkurt İbrahim Halil, Bolat Deniz, Basmacı İsmail, Şefik Ertuğrul, Değirmenci Tansu, Günlüsoy Bülent
Health Science University, Izmir Bozyaka Training and Research Hospital, Urology Clinic, Izmir, Turkey.
Dokuz Eylul University, Institute of Oncology, Department of Basic Oncology, Izmir, Turkey.
Prostate Int. 2020 Dec;8(4):178-184. doi: 10.1016/j.prnil.2020.08.003. Epub 2020 Sep 17.
To investigate the clinical and pathological predictive factors affecting biochemical recurrence (BCR) after radical prostatectomy (RP) in patients with positive and negative surgical margin (SM).
Patients who underwent RP were retrospectively reviewed for the study. Demographic, clinical, pathological and oncological data were evaluated. All data were compared between patients with positive SM and negative SM to detect factors associated with SM status. Later, patients were divided into two groups as BCR-negative and BCR-positive groups. Data were separately compared between BCR groups for all patients, SM-negative and SM-positive patients, respectively.
A total of 254 patients with a mean age of 63.5 years and the mean prostate-specific antigen of 10.9 ng/ml were evaluated in the study. SM positivity was found to be an independent prognostic factor for BCR (p = 0.013, Odds Ratio (OR): 0.267, 95% Confidence Interval (CI): 0.094-0.755). In SM-positive patients, biopsy Gleason Score and International Society of Urological Pathology grade were found to be independent predictive factors for BCR (p < 0.05). However, only tumor to SM distance (TSMD) was found to be an independent risk factor for BCR (p = 0.024) in SM-negative patients. The predictive cutoff value of the TSMD was found to be 75 μm for BCR (100% sensitivity and 63.9% specificity) (AUC = 0.803, p = 0.024). Although all of 46 patients with >75 μm TSMD were recurrence free, 5 of 31 patients with <75 μm TSMD had BCR (p = 0.009; OR: 0.839 CI: 0.719-0.979).
High Gleason Score and International Society of Urological Pathology grade of biopsy were found to be associated with BCR in SM-positive patients. For SM-negative patients, only TSMD was found to be associated with BCR after RP.
探讨手术切缘阳性和阴性患者根治性前列腺切除术后影响生化复发(BCR)的临床和病理预测因素。
对接受根治性前列腺切除术的患者进行回顾性研究。评估人口统计学、临床、病理和肿瘤学数据。比较手术切缘阳性和阴性患者的所有数据,以检测与手术切缘状态相关的因素。随后,将患者分为BCR阴性组和BCR阳性组。分别比较所有患者、手术切缘阴性和阳性患者的BCR组之间的数据。
本研究共评估了254例患者,平均年龄63.5岁,平均前列腺特异性抗原为10.9 ng/ml。手术切缘阳性被发现是BCR的独立预后因素(p = 0.013,比值比(OR):0.267,95%置信区间(CI):0.094 - 0.755)。在手术切缘阳性患者中,活检Gleason评分和国际泌尿病理学会分级被发现是BCR的独立预测因素(p < 0.05)。然而,在手术切缘阴性患者中,仅肿瘤至手术切缘距离(TSMD)被发现是BCR的独立危险因素(p = 0.024)。BCR的TSMD预测临界值为75μm(敏感性100%,特异性63.9%)(曲线下面积(AUC) = 0.803,p = 0.024)。尽管46例TSMD>75μm的患者均无复发,但31例TSMD<75μm的患者中有5例发生了BCR(p = 0.009;OR:0.839,CI:0.719 - 0.979)。
手术切缘阳性患者中,高Gleason评分和活检国际泌尿病理学会分级与BCR相关。对于手术切缘阴性患者,根治性前列腺切除术后仅TSMD与BCR相关。